| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |